 ABC has recently pulled back and provides a potential entry point for investors. Long term, the industry should maintain its 1 share of US expenditure on pharmaceuticals. The Inflation Reduction Act is mainly focused on Medicare Part D. ABC is more heavily exposed to Part B which will be impacted in 2028. 